Indefinite Delivery Contract SPE2DV17D1057

The federal contract IDV award SPE2DV17D1057 is a single-award Indefinite Delivery Contract issued by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of the healthcare services company Cardinal Health, Inc. The contract has a ceiling value of $4,999,999.00 and an ultimate completion date of August 27, 2027. The purpose of this IDC is to provide a flexible procurement mechanism for the DLA to rapidly acquire a diverse range of medical supplies, including surgical dressings, drugs, biologicals, medical consumables, and specialized medical equipment under Federal Supply Group 46 and Federal Supply Class 6515. This contract supports the medical supply chain needs of military treatment facilities and other Department of Defense healthcare providers. Cardinal Health 200, LLC, as a prime contractor, has demonstrated its ability to deliver a comprehensive portfolio of essential medical products and its strategic importance in maintaining the federal government's healthcare supply chain, particularly within the military and defense-related healthcare networks.

The parent company, Cardinal Health, Inc., also holds significant federal contract awards, including indefinite delivery contracts with the Department of Veterans Affairs (VA) for the supply of radiopharmaceuticals used in medical imaging procedures. Additionally, Cardinal Health's subsidiary, The Harvard Drug Group, L.L.C., has secured a single-award IDC with the VA National Acquisition Center for the supply of Lurasidone Hydrochloride tablets, further highlighting the company's extensive experience in managing large-scale pharmaceutical supply agreements with various government agencies.